ProQR to Replace Two Board Members at 2026 AGM, Engages Executive Search
ProQR announced that co-founder Dinko Valerio and board member Alison Lawton will rotate off its board at the 2026 AGM following conclusion of their terms. The company has engaged an executive search firm to identify replacement candidates to strengthen board governance and support long-term value creation as clinical programs advance.
1. Departure of Board Members
ProQR confirmed that co-founder Dinko Valerio and long-standing director Alison Lawton will complete their board terms and step down at the company’s 2026 Annual General Meeting, reflecting the scheduled rotation of their tenures.
2. Executive Search for Replacements
The company has retained an executive search firm to source and nominate new board candidates, aiming to fill skill gaps and ensure a balanced mix of expertise to guide ProQR’s next phase of growth.
3. Board Governance and Succession Planning
As part of ongoing governance reviews, ProQR highlights its commitment to long-term succession planning; the board has added two new members over the past three years to align oversight with advancing clinical pipelines.